Pharmalive

The Pulse of the Pharmaceutical Industry

Therapeutics

Preclinical Study: Lundbeck's Vortioxetine Helps Cognitive Function
Vortioxetine, a new multimodal agent in development for the treatment of major depression, shows effects on cognitive function in several preclinical...
More In: Drug Discovery
An interim analysis showed the drug wasn't helping patients live...
Peregrine rises on agreement for late-stage study WASHINGTON (AP) —...
Vortioxetine clinical phase III data show significant improvement in...

Other News

Oncology

May 22nd, 2013 | 0
•    Efficacy study with 15 patients meets primary endpoint •    EndoTAG®-1 and paclitaxel combination show promising preliminary...Read more
May 22nd, 2013 | 0
•    Everolimus plus trastuzumab and vinorelbine met primary endpoint of extending PFS compared to placebo plus trastuzumab and vinorelbine after...Read more
May 21st, 2013 | 0
Largest-ever global survey of 1,273 women in 12 countries Read more

Cardiovascular

May 22nd, 2013 | 0
ORLANDO, Fla., May 16, 2013 — The hardening of arteries is a hallmark of atherosclerosis, an often deadly disease in which plaques, excessive...Read more
May 22nd, 2013 | 0
Foster City, Calif. – May 16, 2013 – SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that the Company has entered into an agreement...Read more
May 22nd, 2013 | 0
Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent - XIENCE XpeditionTM 48 Leverages Proven Design and Clinical...Read more

Central Nervous System

May 22nd, 2013 | 0
•         ADX71441 produced dose-dependent changes on growth hormone (GH) plasma concentrations in a preclinical model •         The data...Read more
May 22nd, 2013 | 0
By Mia Burns UCB and IBM have completed the initial phase of a project designed to harness the power of analytics to help healthcare...Read more
May 22nd, 2013 | 0
•      Project Will Use Big Data and Analytics to Address Pressing Public Health Issue ARMONK, NY and BRUSSELS – May 16, 2013 – regulated...Read more

Pain & Inflammation

May 21st, 2013 | 0
Sanofi and Regeneron Announce...Read more
May 20th, 2013 | 0
Relmada Therapeutics retains...Read more
May 20th, 2013 | 0
Atlantic Pharmaceuticals...Read more

Infectious Disease

May 22nd, 2013 | 0
The vaccine based on Cytos’ Virus-Like Particle technology may open the door to accelerated production of influenza vaccines in Singapore....Read more
May 22nd, 2013 | 0
GlaxoSmithKline awarded up to $200 million by U.S. government to develop new antibiotics -    Award is first of its kind public-private...Read more
May 21st, 2013 | 0
Primary Efficacy and Safety...Read more

Topics

Resources